Reply to comment on: Haubitz et al. Outcome of Clostridioides difficile infections treated in a Swiss tertiary care hospital: an observational study

Sebastian Haubitz; Christoph A. Fux

doi:10.4414/smw.2021.20311

Author reply to technical comment

Vol. 151 No. 0102 (2021)

Reply to comment on: Haubitz et al. Outcome of Clostridioides difficile infections treated in a Swiss tertiary care hospital: an observational study

Sebastian Haubitz
Christoph A. Fux

DOI: https://doi.org/10.4414/smw.2021.20311
Cite this as:: Swiss Med Wkly. 2021;151:w20311
Published: 04.01.2021

References

Haubitz S, Bartlomé N, Bucheli Laffer E, Spelters C, Fankhauser H, Fux CA. Outcome of Clostridioides difficile infections treated in a Swiss tertiary care hospital: an observational study. Swiss Med Wkly. 2020;150:w20173. doi:.https://doi.org/10.4414/smw.2020.20173
Zha M, Rena X, Lub J, Luoc J. Comment on: Haubitz et al. Outcome of Clostridioides difficile infections treated in a Swiss tertiary care hospital: an observational study. Swiss Med Wkly. 2020;150:w20310.
Collins DA, Sohn KM, Wu Y, Ouchi K, Ishii Y, Elliott B, et al.; Clostridioides difficile Asia-Pacific Study Group. Clostridioides difficile infection in the Asia-Pacific region. Emerg Microbes Infect. 2020;9(1):42–52. doi:.https://doi.org/10.1080/22221751.2019.1702480
Tschudin Sutter S, Boggian K, Bernasconi E, Guery B, Achermann Y. Clostridioides difficile-Infektion. 22 January 2020. Available at: https://ssi.guidelines.ch/guideline/3120 [cited 2020 May 14].

How to Cite

1.

Haubitz S, Fux CA. Reply to comment on: Haubitz et al. Outcome of Clostridioides difficile infections treated in a Swiss tertiary care hospital: an observational study. Swiss Med Wkly [Internet]. 2021 Jan. 4 [cited 2024 Dec. 3];151(0102):w20311. Available from: https://smw.ch/index.php/smw/article/view/2938

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Most read articles by the same author(s)

Claudia Gregoriano, Kris Rafaisz, Philipp Schuetz, Beat Mueller, Christoph A. Fux, Anna Conen, Alexander Kutz, Burden of disease in patients hospitalised with COVID-19 during the first and second pandemic wave in Switzerland: a nationwide cohort study , Swiss Medical Weekly: Vol. 153 No. 5 (2023)
Sebastian Gross, Katharina Beck, Christoph Becker, Martina Gamp, Jonas Mueller, Nina Loretz, Simon A. Amacher, Chantal Bohren, Jens Gaab, Philipp Schuetz, Beat Mueller, Christoph A. Fux, Jörg D. Leuppi, Rainer Schaefert, Wolf Langewitz, Marten Trendelenburg, Tobias Breidthardt, Jens Eckstein, Michael Osthoff, Stefano Bassetti, Sabina Hunziker, Perception of physicians and nursing staff members regarding outside versus bedside ward rounds: ancillary analysis of the randomised BEDSIDE-OUTSIDE trial , Swiss Medical Weekly: Vol. 152 No. 0304 (2022)
Andrea Bregenzer, Cornelia Krismer, Stefanie Wendel, Patrik Roser, Christoph A. Fux, HCV elimination in a Swiss opioid agonist therapy programme – a cohort study , Swiss Medical Weekly: Vol. 152 No. 4950 (2022)
Claudia Gregoriano, Daniel Koch, Sebastian Haubitz, Anna Conen, Christoph A. Fux, Beat Mueller, Luca Bernasconi, Angelika Hammerer-Lercher, Michael Oberle, Susanne Burgemeister, Hartwig Reiter, Alexander Kutz, Philipp Schuetz, Characteristics, predictors and outcomes among 99 patients hospitalised with COVID-19 in a tertiary care centre in Switzerland: an observational analysis , Swiss Medical Weekly: Vol. 150 No. 2930 (2020)
Selina Wolfisberg, Claudia Gregoriano, Tristan Struja, Alexander Kutz, Daniel Koch, Luca Bernasconi, Angelika Hammerer-Lercher, Christine Mohr, Sebastian Haubitz, Anna Conen, Christoph A. Fux, Beat Mueller, Philipp Schuetz, Comparison of characteristics, predictors and outcomes between the first and second COVID-19 waves in a tertiary care centre in Switzerland: an observational analysis , Swiss Medical Weekly: Vol. 151 No. 3132 (2021)
Andrea Bregenzer, Cornelia Ottiger, Cornelia Krismer, Karin Sager, Christoph A. Fux, HCV RNA quantification in capillary dried blood spots with the Xpert® HCV Viral Load test for diagnosing chronic HCV infection, monitoring treatment and detecting reinfection , Swiss Medical Weekly: Vol. 151 No. 5152 (2021)
Sebastian Haubitz, Nicole Bartlomé, Evelin Bucheli Laffer, Constanze Spelters, Hans Fankhauser, Christoph A. Fux, Outcome of Clostridioides difficile infections treated in a Swiss tertiary care hospital: an observational study , Swiss Medical Weekly: Vol. 150 No. 0102 (2020)
Sophie Schürch, Christoph A. Fux, Silvia Dehler, Anna Conen, Jürg Knuchel, Andrée Friedl, Franz Eigenmann, Patrik Roser, Peter Ackle, Andrea Bregenzer, Management of hepatitis C in opioid agonist therapy patients of the Swiss canton Aargau within and outside the cohort study , Swiss Medical Weekly: Vol. 150 No. 3132 (2020)
Andrea Haubitz-Eschelbach, Mirsada Durmisi, Sebastian Haubitz, Alexander Kutz, Beat Mueller, Jeffrey L. Greenwald, Philipp Schuetz, The glory of the age is the wisdom of grey hair: association of physician appearance with outcomes in hospitalised medical patients – an observational study , Swiss Medical Weekly: Vol. 149 No. 5152 (2019)

[1] Haubitz S, Bartlomé N, Bucheli Laffer E, Spelters C, Fankhauser H, Fux CA. Outcome of Clostridioides difficile infections treated in a Swiss tertiary care hospital: an observational study. Swiss Med Wkly. 2020;150:w20173. doi:.https://doi.org/10.4414/smw.2020.20173

[2] Zha M, Rena X, Lub J, Luoc J. Comment on: Haubitz et al. Outcome of Clostridioides difficile infections treated in a Swiss tertiary care hospital: an observational study. Swiss Med Wkly. 2020;150:w20310.

[3] Collins DA, Sohn KM, Wu Y, Ouchi K, Ishii Y, Elliott B, et al.; Clostridioides difficile Asia-Pacific Study Group. Clostridioides difficile infection in the Asia-Pacific region. Emerg Microbes Infect. 2020;9(1):42–52. doi:.https://doi.org/10.1080/22221751.2019.1702480

[4] Tschudin Sutter S, Boggian K, Bernasconi E, Guery B, Achermann Y. Clostridioides difficile-Infektion. 22 January 2020. Available at: https://ssi.guidelines.ch/guideline/3120 [cited 2020 May 14].